Spring 2020 Independent Advisory Panel
Saurabha Bhatnagar, MD
- Chief Medical Officer, Head of Technology & Performance, UnitedHealthcare
Dr. Saurabha Bhatnagar leverages his deep knowledge of medicine, technology, human centered design, and quality to drive healthcare innovation globally. He is a computer scientist turned Physical Medicine & Rehabilitation (PM&R) physician. Dr. Bhatnagar is the Chief Medical Officer, Head of Technology & Performance at UnitedHealthcare (UHC), a Fortune 5 company.
Prior to joining UHC, he served as the Deputy Chief Medical Officer for Electronic Health Record Modernization (EHRM) in the US Department of Veterans Affairs (VA). EHRM is a $16+ billion program deploying a new operational system across 150+ VA hospital systems and 1000+ outpatient centers of care impacting ~9 million Veterans annually and ~330,000 employees in all 50 states. During his tenure in the VA, he held enterprise-level, senior executive roles as the Assistant Deputy Undersecretary for Health for Quality/Safety/Value (Chief of QSV), Chief Medical Information Officer for EHRM, Deputy Assistant Deputy Undersecretary for Health for QSV (Vice Chief/Chief of Staff of QSV), & Innovation Officer. In these roles, he led the formulation and establishment of national healthcare policies, programs, and operational initiatives that fulfill the enterprise mission of providing safe, reliable, and high-quality healthcare.
Dr. Bhatnagar is faculty at Harvard Medical School, where he has served as Associate Director - PM&R Residency Program. Dr. Bhatnagar earned a bachelors in Computer Science with Honors from Illinois Institute of Technology (IllinoisTech) and doctorate from Chicago Medical School-RFUMS. He completed a PM&R Residency at Wayne State University-Oakwood and a Traumatic Brain Injury / Neurorehabilitation Fellowship at Harvard Medical School.
In 2019, IllinoisTech awarded him the Outstanding Young Alumnus award and VA awarded him the Deputy Undersecretary of Health Commendation. He has been a Visiting Professor and a keynote speaker globally focusing on health technology strategy & operations.
Bonnie Charland, PhD
- Associate Director of Quality Management, VA Boston Healthcare System
Heather Davidson, MD
- Deputy Chief of Staff, VA Boston HCS; Hospitalist
- Assistant Professor at Boston University School of Medicine
- Chief Commercial Officer, Mymee
Melinda Decker is a global biopharmaceutical leader with a rare mix of both commercial and R&D expertise, developed over nearly 20 years in the pharmaceutical-biotech industry. She has broad therapeutic experience with biologic, small molecule and digital health products, across both specialty and primary care, and with both global and local markets.
Most recently she was the Oncology TA Head for AstraZeneca’s digital therapeutics team, focused on improving patient outcomes through digital health. In this role, she worked to integrate medicines with technology such as connected devices, sensors, and smart packaging across the entire development cycle of launched, pre-launched, late-stage pipeline, and early clinical development products. These tools helped improve adherence, manage adverse events, improve how clinical trials are run, and collect real-world evidence. Philadelphia Business Journal honored her as a 2018 Health Care Innovator for this work. Previously, she was AstraZeneca’s Diabetes TA head for digital health. Melinda joined AstraZeneca initially through MedImmune in 2011, where she led the Commercial Innovation department.
Prior to joining AstraZeneca, Melinda worked at Pfizer for 10 years, in various roles of increasing responsibilities, including commercial leadership roles, on key blockbuster products Enbrel, Protonix and Effexor. At Pfizer, Melinda held roles in global and US marketing, manufacturing, portfolio and alliance management, strategic planning and sales. She also had responsibilities in public and investor relations.
Melinda’s therapeutic experience is extensive, including Inflammation, Rheumatology, Dermatology, Oncology, Infectious Disease, Pediatrics, Gastroenterology, Diabetes, Neuroscience, and Respiratory.
She holds an MS in Biochemical Engineering and an MBA in Finance and Marketing, both from University of California, Davis.
Samuel “Mooly” Dinnar
- Founder of Meedance
- Instructor at Harvard and MIT
- Author of "Entrepreneurial Negotiation"
Samuel Dinnar is a mediator, consultant and board advisor with more than 25 years of international experience as an entrepreneur, executive, board member and venture capital investor. He is an instructor at the Program on Negotiation at Harvard Law School, teaches negotiation and mediation at the Harvard Negotiation Institute, educates executives internationally with PON Global and is a research Associate with MIT’s Science Impact Collaborative.
Dinnar is founder and president of Meedance, a company providing negotiation, training, coaching and dispute resolution services to facilitate clients’ business success with improved results and relationships. He builds on two decades of general management, strategic growth and operations team leadership in hi-‐tech and aerospace, including two start-‐ups that revolutionized their industry, while dealings across various continents and cultures.
Dinnar’s academic education includes technical degrees in both aerospace engineering and computer sciences, and a PMD from the Harvard Business School. He is also an FAA-certified flight instructor and rated jet pilot.
Dinnar is the co-author of the 2019 award winning book “Entrepreneurial Negotiation: Understanding and Managing the Relationships that Determine Your Entrepreneurial Success” (Palgrave Macmillan), which serves as the foundation for a new course at MIT with same title.
Dinnar has helped develop and teach courses and advanced courses in Mediation, Negotiation & Leadership, both at Harvard and to many entrepreneurs and executives around the globe. Recently, in places such as London, Tel Aviv, Mexico City, Hong Kong, Athens, Nicosia, and Rome.
- CEO of OptimizeRx
Connecting the Pharma & Healthcare industry with compliant innovation has been Febbo’s trademark in over 18 years of leading health service & technology companies. In 1999, he co-founded MedPanel, a market intelligence and communication provider to the biomedical & medical device industries. When Febbo sold it in 2007 to Merriman Capital, he held dual roles as COO of the bank and CEO of Digital Capital Network which he launched pioneering digital compliance & transparency in the financial industry.
Febbo is also founder of Plexuus, an early stage payment processing platform for medical professionals with Sunshine Act-related activities. Currently, he holds the position of CEO at OptimizeRX and continues to discover, innovate and connect both products and people to meaningful experiences to improve health outcomes. Febbo holds a Bachelor of Arts in International Studies from Dickinson College, in Pennsylvania and serves on the board of The United Nations of Greater Boston, a non-profit focused on building global citizens within inner-city schools in Massachusetts.
Christiana Iyasare, MD
- Director, Massachusetts General Hospital Department of Medicine Innovation Program
- Co-Founder, Dyrnamix, Inc.
Nahun (Nani) Kim is a designer, design researcher, and an innovator who strives to highlight the value of human centered design in product development process. She obtained her BFA in Industrial Design at RISD in 2015, and is currently pursuing Master of Science in Engineering and Management at MIT Integrated Design and Management. At the MIT IDM Program, she is combining her design background with business and engineering to become a versatile designer that can manage diverse aspects of product development process from the research and ideation process to product launch.
During her career life previous to MIT, she worked at LG Hausys for four years as a surface product designer. As a surface product designer, she researched material needs in healthcare, commercial, and residential markets. Nani particularly focused most of her research on the healthcare market as it was a growing market with specific materials demands. She designed antibacterial acrylic solid surfaces adequate for healthcare application. To make surfaces more usable in healthcare applications, she also designed ADA compliant sink products that fit the user needs. Her surface products and sink products are applied in a number of healthcare facilities and senior living homes today.
As a Catalyst fellow, she will continue to answer to the healthcare market needs. She will utilize human centered design approaches in identifying unmet needs in the healthcare market.
Terry Keane, PhD
- Associate Chief of Staff for Research and Development at VA Boston Healthcare System
- Director of the National Center for Post-traumatic Stress Disorder’s Behavioral Science Division
- Digital Integration at CVS Health
Daphne Psacharopoulos leads digital strategy and integration for the CVS Health enterprise digital team. She joined CVS in 2016 to lead digital strategy and product management for the specialty pharmacy where she and her team launched products used by >80% of patients and by providers. Before joining CVS, she was Sr. Vice President and served on the management team at PatientsLikeMe, an online patient community and research network.
Previously, she founded and led Healthcare Services at Joslin Diabetes Center, which commercialized Joslin’s expertise nationally, and had overall responsibility for P&L, strategy, product development, business development & operations. Earlier in her career, she was a consultant and principal in the health care practice of Boston Consulting Group and an economist with Exeter Associates.
She serves on the board of directors for Grass Roots Diabetes, a non-profit dedicated to improving health outcomes for people living with diabetes. She holds a degree in finance from McGill University and an MBA from Tuck/Dartmouth. She lives with her husband and three children in Newton, MA.
Jagesh Shah, PhD
- Vice President, Gene Therapy Technologies at Sana Biotechnology, Inc.
Smrithi Sunil is a PhD student in the Biomedical Engineering Department at Boston University. She received her BS in Biomedical Engineering with a minor in Electrical Engineering from Case Western Reserve University in May 2015. During her undergrad, she worked with Dr. Jeffrey Capadona on characterizing the inflammatory response that results from intracortical microelectrode implants. She worked on engineering solutions to minimize the deleterious effects of the inflammatory response and improve longevity of the implanted electrodes.
Her current research with Dr. David Boas is focused on understanding the impact of stroke on neurovascular coupling. She is using multimodal imaging techniques to characterize the structural and functional changes following a stroke in rodents. The goal of Smrithi’s project is to evaluate the evolution of structural and functional components of neurovascular recovery to understand the effects of these elements on neurovascular coupling and thereby better interpret fMRI signals in humans during stroke recovery.
Smrithi is constantly thinking about the translational potential and the direct impact of the research projects she is involved with and is passionate about developing impactful technologies to improve healthcare.
Barry Stein, MD, MBA, FSIR, FACR, RPVI
- Chief Clinical Innovation Officer at Hartford HealthCare
Frances Toneguzzo, PhD
Intellectual Property and Business Strategy Consultant